期刊文献+

PARP-1、CK7/20和p53在Barrett食管和食管腺癌中的表达及意义 被引量:2

PARP-1, CK7/20 and p53 in Barrett's esophagus and esophageal adenocarcinoma: expression and its significance
原文传递
导出
摘要 目的研究PARP-1、CK7/20、p53在Barrett食管和食管腺癌中的表达并探讨其临床意义。方法应用免疫组化法测定40例Barrett食管,28例食管腺癌和40例贲门黏膜组织中PARP-1、CK7/20、p53蛋白的表达。结果PARP-1在贲门黏膜、Barrett食管和食管腺癌中均有阳性表达,但在食管腺癌中的阳性率明显高于其他两组(P〈0.01);CK7/20在肠化上皮细胞胞质、部分贲门柱状上皮和腺癌上皮细胞质内呈阳性表达;而p53在3组中均有阳性表达,且食管腺癌中阳性率明显高于其他两组(P〈0.05);PARP-1与p53表达在BE组存在明显相关性(r=0.49,P〈0.01)。结论CK7/20可作为诊断肠上皮化生的敏感指标,但特异性欠佳。PARP-1和p53与Barrett食管及食管腺癌有关,检测PARP-1和p53对判断Barrett食管癌变风险有一定价值。 Objective To investigate the expression of poly (ADP-ribose) polymerase-1 (PARP- 1 ) , cytokeratins (CK) 7/20, and p53 in patients with Barrett's esophagus and esophageal adenocarcinoma, and to evaluate their significance. Methods Expression of PARP-1, CK7/20 and p53 were determined by immunohistochemistry in 108 patients (including 40 Barrett's esophagus, 28 esophageal adenocarcinoma and 40 cardiac mucosa). Results The expression of PARP-1 was found in Barrett's esophagus, esophageal ade- nocarcinoma and cardiac epithelium with a significantly higher level in esophageal adenocarcinoma than the other two groups (P 〈 0. 01 ). CK7/20 was expressed in much of intestinal metaplasia, part of cardiac epi- thelium and ad cells. The positive expression of p53 was observed in all three groups, and it was significantly higher in adenocarcinoma group than in other two groups (P 〈 0. 05 ). PARP-1 expression is highly correlated with that of p53 in Barrett's esophagus ( r = 0.49, P 〈 0.01 ). Conelusion CK7/20 is a sensitive but less specific indicator for intestinal metaplasia. Both PARP-1 and p53 are involved in the patho- genesis of esophageal adenocarcinoma and might help to determine the risk of Barrett's esophagus developing into esophageal adenocarcinoma.
出处 《中华消化内镜杂志》 2008年第6期304-308,共5页 Chinese Journal of Digestive Endoscopy
基金 人事部回国人员科技活动项目[(2005)129号]
关键词 BARRETT食管 腺癌 诊断 Barrett esophagus Adenocarcinoma Diagnosis
  • 相关文献

参考文献15

  • 1Wolfsen HC. Present status of photodynamic therapy for high- grade dysplasia in Barrett's esophagus. J Clin Gastroenterol, 2005,39 : 189-202. 被引量:1
  • 2Burkle A. Physiology and pathophysiology of poly(ADP-ribosyl)ation. Bioessays,2001,23 :795-806. 被引量:1
  • 3Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol, 2002,97 : 1888-1895. 被引量:1
  • 4Ormsby AH, Vaezi MF, Richter JE, et al. Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus. Gastroenterology ,2000,119:683-690. 被引量:1
  • 5Mohammed IA, Streutker C J, Riddell RH. Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia. Mod Pathol,2002,15: 611-616. 被引量:1
  • 6Yim HJ, Lee SW, Choung RS, et al. Is cytokeratin immunoreactivity useful in the diagnosis of short-segment Barrett's oesophagus in Korea? Eur J Gastroenterol Hepatol,2005 ,17 :611-616. 被引量:1
  • 7Clemons NJ, McColl KE, Fitzgerald RC. Nitric oxide and acid induce double-strand DNA breaks in Barrett's esophagus carcinogenesis via distinct mechanisms. Gastroenterology, 2007,133 : 1198-1209. 被引量:1
  • 8Jenkins GJ, D'Souza FR, Suzen SH, et al. Deoxycholic acid at neutral and acid pH, is genotoxic to oesophageal ceils through the induction of ROS: The potential role of anti-oxidants in Barrett's oesophagus. Carcinogenesis,2007,28 : 136-142. 被引量:1
  • 9Nosho K, Yamamoto H, Mikami M, et al. Overexpression of poly(ADP-ribose) polymerase-1 (PARP-1) in the early stage of colorectal carcinogenesis. Eur J Cancer,2006,42:2374-2381. 被引量:1
  • 10Barrett MT, Sanchez CA, Prevo LJ, et al. Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet, 1999,22: 106-109. 被引量:1

同被引文献59

  • 1坂上隆,栾昌海.上消化道疾病[J].日本医学介绍,2007,28(7):323-326. 被引量:6
  • 2Baxrett NR. Chronic peptic ulcer of the oesophagus and oes0phagitis[J]. Br J Surg, 1950, 38(150): 175-182. 被引量:1
  • 3星橘芳雄,木暮需,山本敬,他.ShortsegmentBarrett'sesophagusの诊断[J].胃と肠,1999,34(1):133-139. 被引量:1
  • 4Canto MI, Yoshida T, Gossner L. Chromoscopy of intestinal metaplasia in Barrett esophagus[J]. Endoscopy, 2002, 34(4): 330-336. 被引量:1
  • 5Wang KK, Sampliner RE, Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagns[J]. Am J Gastroenterol, 2008, 103(3): 788-797. 被引量:1
  • 6Fitzgerald PC, di PieU'o M, Ragunath K, et al. British society of gastroenterology guidelines on the diagnosis and management of Barrett's oesophagns[J]. Gut, 2014, 63(1): 7-42. 被引量:1
  • 7Lin W, Hahn H, Odze RD, et al. Me taplastic esophageal eolunmar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell-containing epithelium[J]. Am J Gastroenterol, 2009, 104(4): 816-824. 被引量:1
  • 8Takubo K, Aida J, Naomoto Y, et al. Cardiac rather than intestinal-type background in endoscopic reseetion specimens of minute Barrett adenocareinoma[J]. Hum Pathol, 2009, 40(1): 65-74. 被引量:1
  • 9Rosztoczy A, Izboki F, R6ka R, et al. The evaluation of oesophageal function in patients with different types of oesophageal metaplasia[J]. Digestion, 2011, 84(4): 273-280. 被引量:1
  • 10Gatenby PA, Caygill CP, Ramus JR, et al. Barrett's columnar-lined oesophagus:, demographic and lifestyle associations and adenocarcinoma risk[J]. Dig Dis Sci, 2008, 53(5): 1175-1185. 被引量:1

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部